Insulin showdown: which works better for kids with diabetes in poor regions?
NCT ID NCT05614089
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study tested whether a newer insulin (glargine) is safer and better at controlling blood sugar than standard human insulin in 400 youth aged 7-25 with type 1 diabetes living in low-resource settings. Participants used continuous glucose monitors to track their levels over 6-12 months. The goal was to see if glargine reduces dangerous low blood sugar episodes and improves time in the target glucose range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BIRDEM Hospital
Dhaka, Bangladesh
-
Bugando Medical Center
Mwanza, Tanzania
-
Sekou-Toure Hospital
Mwanza, Tanzania
Conditions
Explore the condition pages connected to this study.